Cargando…

The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report

The purpose of this study is to report a case in which standard medication protocols for postherpetic neuralgia (PHN) led to adverse effects and insufficient results. The dead end that occurred in association with the patient’s deteriorating general condition and hesitation to comply with oral medic...

Descripción completa

Detalles Bibliográficos
Autor principal: Tsoleridis, Theofilos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013313/
https://www.ncbi.nlm.nih.gov/pubmed/36925972
http://dx.doi.org/10.7759/cureus.34886
_version_ 1784906787543056384
author Tsoleridis, Theofilos
author_facet Tsoleridis, Theofilos
author_sort Tsoleridis, Theofilos
collection PubMed
description The purpose of this study is to report a case in which standard medication protocols for postherpetic neuralgia (PHN) led to adverse effects and insufficient results. The dead end that occurred in association with the patient’s deteriorating general condition and hesitation to comply with oral medication due to fear led to the application of transdermal buprenorphine (TDB) after written informed consent was obtained. TDB application in acute cases is still under study, and the literature is limited. A 78-year-old female presenting with intense PHN was treated with pregabalin and paracetamol but complained of inadequate pain control and intense somnolence. TDB 35 μg/hour was applied after written consent was given. Six hours later, the situation improved, while five days later, the patient recovered completely. The patch was removed on the sixth day after application. In the follow-up after two weeks, no neuropathic symptoms or adverse effects were reported. The optimal results of TDB application were substantially represented by excellent and continuous pain control, improved quality of life, and patient compliance due to the pharmacological properties of buprenorphine and easy patch application. The patient’s rapid response to TDB’s soothing action is an encouraging factor for its application in studies regarding PHN and acute pain attacks in general.
format Online
Article
Text
id pubmed-10013313
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-100133132023-03-15 The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report Tsoleridis, Theofilos Cureus Pain Management The purpose of this study is to report a case in which standard medication protocols for postherpetic neuralgia (PHN) led to adverse effects and insufficient results. The dead end that occurred in association with the patient’s deteriorating general condition and hesitation to comply with oral medication due to fear led to the application of transdermal buprenorphine (TDB) after written informed consent was obtained. TDB application in acute cases is still under study, and the literature is limited. A 78-year-old female presenting with intense PHN was treated with pregabalin and paracetamol but complained of inadequate pain control and intense somnolence. TDB 35 μg/hour was applied after written consent was given. Six hours later, the situation improved, while five days later, the patient recovered completely. The patch was removed on the sixth day after application. In the follow-up after two weeks, no neuropathic symptoms or adverse effects were reported. The optimal results of TDB application were substantially represented by excellent and continuous pain control, improved quality of life, and patient compliance due to the pharmacological properties of buprenorphine and easy patch application. The patient’s rapid response to TDB’s soothing action is an encouraging factor for its application in studies regarding PHN and acute pain attacks in general. Cureus 2023-02-12 /pmc/articles/PMC10013313/ /pubmed/36925972 http://dx.doi.org/10.7759/cureus.34886 Text en Copyright © 2023, Tsoleridis et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pain Management
Tsoleridis, Theofilos
The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report
title The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report
title_full The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report
title_fullStr The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report
title_full_unstemmed The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report
title_short The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report
title_sort use of transdermal buprenorphine for acute postherpetic neuralgia: a case report
topic Pain Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013313/
https://www.ncbi.nlm.nih.gov/pubmed/36925972
http://dx.doi.org/10.7759/cureus.34886
work_keys_str_mv AT tsoleridistheofilos theuseoftransdermalbuprenorphineforacutepostherpeticneuralgiaacasereport
AT tsoleridistheofilos useoftransdermalbuprenorphineforacutepostherpeticneuralgiaacasereport